Advert - Proveca

• Date posted
  08 August 2019
• Sanction
  Advertisement,
• Case number/s
  AUTH/3060/8/18 - Pharmacist v Proveca

For a letter sent to individual pharmacists about the supply of unlicensed and off-label glycopyrronium vs the use of its own product, Sialanar (glycopyrronium bromide), and which could be seen as threatening in tone, Proveca was ruled in breach of the following clauses: 

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 9.1 - Failing to maintain high standards.